5-HT1B antagonists modulate clearance of extracellular serotonin in rat hippocampus

Neurosci Lett. 1999 May 14;266(3):165-8. doi: 10.1016/s0304-3940(99)00277-3.

Abstract

In vivo chronoamperometry was used to determine the effects of locally applied antagonists of the serotonin-1B (5-HT1B) receptor (cyanopindolol, 5-HT-moduline and methiothepin) on the clearance of 5-HT in the CA3 region of the dorsal hippocampus and the corpus callosum (a brain region devoid of serotonin transporters and 5-HT1B receptors) of the rat. When 5-HT was pressure ejected into these regions, reproducible signals were detected. In the CA3 region, local application of 5-HT1B antagonists decreased the rate of clearance of the serotonin signal comparably to the selective 5-HT uptake inhibitor (SSRI), fluvoxamine. By contrast, in the corpus callosum, none of the drugs altered the 5-HT signal. One interpretation of these data is that 5-HT1B receptors can modulate the activity of the 5-HT transporter.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Analysis of Variance
  • Animals
  • Corpus Callosum / drug effects
  • Corpus Callosum / metabolism
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Male
  • Metabolic Clearance Rate
  • Methiothepin / pharmacology
  • Neuropeptides / pharmacology
  • Oligopeptides / pharmacology
  • Pindolol / analogs & derivatives
  • Pindolol / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Serotonin / metabolism*
  • Serotonin Antagonists / pharmacology*

Substances

  • 5-HT-moduline
  • Neuropeptides
  • Oligopeptides
  • Serotonin Antagonists
  • Serotonin
  • cyanopindolol
  • Methiothepin
  • Pindolol